Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Dec. 25, 2022	Dec. 26, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 1,290,500	$ (1,085,200)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation and amortization	1,592,800	1,878,400
Stock-based compensation expense	796,500	724,700
Change in trade accounts receivable	(3,951,100)	1,658,800
Change in product inventory	(14,910,400)	2,735,300
Change in prepaid expenses and other current assets	(1,511,500)	446,100
Change in income taxes receivable	3,670,200	3,062,600
Change in other assets and other liabilities	(1,695,500)	(887,200)
Change in trade accounts payable	3,855,000	(6,057,800)
Change in payroll, benefits and taxes	1,150,700	(1,198,300)
Change in sales tax liabilities	95,200	(111,900)
Change in accrued expenses and other current liabilities	541,700	(867,900)
Net cash provided by (used in) operating activities	(9,075,900)	297,600
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(13,501,900)	(7,988,300)
Net cash provided by (used in) investing activities	(13,501,900)	(7,988,300)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings from revolving line of credit long term	220,846,400	204,515,300
Repayments to revolving line of credit long term	(196,177,000)	(196,827,000)
Payments of debt issuance costs	(222,300)
Payments on long term debt	(264,000)
Proceeds from issuance of stock	70,600	81,000
Repurchase of stock from employees and directors for minimum tax withholdings	(158,100)	(66,400)
Net cash provided by (used in) financing activities	24,095,600	7,702,900
Net increase (decrease) in cash and cash equivalents	1,517,800	12,200
CASH AND CASH EQUIVALENTS, beginning of period	1,754,000	1,110,000
CASH AND CASH EQUIVALENTS, end of period	3,271,800	1,122,200
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Capital expenditures included in accounts payable	$ 1,639,800	$ 3,362,900